Zygomycosis risk factors: Difference between revisions

Jump to navigation Jump to search
Shankar Kumar (talk | contribs)
No edit summary
Shankar Kumar (talk | contribs)
No edit summary
Line 5: Line 5:
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
==Overview==
==Overview==
While most individuals are exposed to the fungi on a regular basis those with immune disorders are more prone to an infection.<ref name=medplus>{{cite web |url=http://www.nlm.nih.gov/medlineplus/ency/article/000649.htm |title=MedlinePlus Medical Encyclopedia: Mucormycosis |format= |work= |accessdate=2008-04-21}}</ref> In humans zygomycosis is most prevalent in immunocompromised patients ([[AIDS|HIV/AIDS]], the [[old age|elderly]], [[Severe combined immunodeficiency|SCID]], etc) and patients in [[acidosis]] ([[diabetes]], burns), particularly after barrier injury to the skin or [[mucus membrane]]s.
While most individuals are exposed to the fungi on a regular basis those with immune disorders are more prone to an infection.<ref name=medplus>{{cite web |url=http://www.nlm.nih.gov/medlineplus/ency/article/000649.htm |title=MedlinePlus Medical Encyclopedia: Mucormycosis |format= |work= |accessdate=2008-04-21}}</ref> In humans zygomycosis is most prevalent in immunocompromised patients ([[AIDS|HIV/AIDS]], the [[old age|elderly]], [[Severe combined immunodeficiency|SCID]], etc) and patients in [[acidosis]] ([[diabetes]], burns), particularly after barrier injury to the skin or [[mucus membrane]]s, malignancies such as [[lymphoma]]s and [[leukemia]]s, [[renal failure]], [[organ transplant]], long term [[corticosteroid]] and immunosuppressive therapy, [[cirrhosis]], [[burns]] and energy [[malnutrition]].


==References==
==References==

Revision as of 15:17, 13 December 2012

Zygomycosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Zygomycosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Zygomycosis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Zygomycosis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Zygomycosis risk factors

CDC on Zygomycosis risk factors

Zygomycosis risk factors in the news

Blogs on Zygomycosis risk factors

Directions to Hospitals Treating Zygomycosis

Risk calculators and risk factors for Zygomycosis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

While most individuals are exposed to the fungi on a regular basis those with immune disorders are more prone to an infection.[1] In humans zygomycosis is most prevalent in immunocompromised patients (HIV/AIDS, the elderly, SCID, etc) and patients in acidosis (diabetes, burns), particularly after barrier injury to the skin or mucus membranes, malignancies such as lymphomas and leukemias, renal failure, organ transplant, long term corticosteroid and immunosuppressive therapy, cirrhosis, burns and energy malnutrition.

References

  1. "MedlinePlus Medical Encyclopedia: Mucormycosis". Retrieved 2008-04-21.


Template:WikiDoc Sources